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Organophosphorus inactivators of serine esterases inhibit the chemotactic response 
of rabbit polymorphonuclear leukocytes to  the  complement-dependent  chemotactic 
factor (1).1 The organophosphorus inhibitors employed in demonstrating this inhibition 
were mainly several homologous series of phosphonate esters. Two  general types of 
experimental procedures were used to  elicit the inhibition of the chemotactic respon- 
siveness of the leukocytes. In the first, inhibition was obtained on incubating leuko- 
cytes with a  phosphonate  ester in  the absence of the chemotactic factor. The ceils 
when washed free of inhibitor were shown to have lost their ability to respond to the 
chemotactic factor. This was termed "ceil-dependent inhibition." In the second pro- 
cedure, cells suspended in a phosphonate inhibitor and placed in the upper  compart- 
ment of a  chamber used  to measure chemotactic response  were acted upon by the 
chemotactic factor diffusing from  the lower compartment. The inhibition obtained 
under  these  conditions was  called  "chemotactic factor--dependent inhibition."  The 
concentration of inhibitor,  kind of phosphonate, and duration of contact of cells and 
inhibitor were  manipulated so that  a  high  degree of chemotactic factor--dependent 
inhibition was obtainable in the complete absence of cell-dependent inhibition (1). 
It was concluded that these two kinds of inhibition were due to the inactivation of 
two  serine esterases. In the cell-dependent reaction, there is inhibition of what we 
term the "activated esterase." This esterase exists in or on the leukocyte in an already 
activated state and is, therefore, inhibitable by organophosphorus compounds in the 
absence of  the  chemotactic factor.  The  chemotactic factor-dependent inhibition is 
considered due to the inhibition of a  second esterase which we term the "activatable 
* This work was supported by the National Institutes of Health, Bethesda,  Md., Grant 
No. AI 07291 AIA. 
a The complement-dependent  chemotactic factor used in the preceding and present paper 
is the activated complex of the fifth,  sixth, and seventh components  of complement  (C'5, 
C'6, C'7). 
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esterase." This enzyme is present in or on the cell in a  precursor form which is not 
susceptible to inactivation by the organophosphorus inhibitor. The chemotactic factor 
activates this esterase; the esterase then is capable of being inhibited by the organo- 
phosphorus compound (1). 
In the preceding study, the esterases were characterized only by their ability to be 
inhibited by several homologous series  of p-nitrophenylethyl phosphonates. In order 
to establish the exact role of these enzymes in the chemotactic process it is both de- 
sirable and necessary to isolate the esterases from the leukocytes in pure form, and 
establish their precise biochemical function. For this purpose it is requisite  that addi- 
tional means of characterizing the esterases be available so that even though free oi 
the cell they still can be identified as the specific esterases concerned with chemotaxis. 
It is  the furnishing of such a further identifying characteristic for the activated ester- 
ase of chemotaxis which is the subject of this paper. 
Organophosphorus inhibitors, like the phosphonate esters,  inactivate serine esterases 
by irreversibly binding to the active site of the enzyme. As repeatedly shown, sub- 
strates or competitive inhibitors which combine reversibly with the active site of the 
serine esterase, when present at the same time as the organophophoms inhibitor, can 
protect  the enzyme from inactivation  by preventing access  of the inhibitor  to the 
enzymatic site (reviewed in reference 2). 
With this in mind, a wide variety of simple carboxylic acid esters, amino acid 
esters,  and  phosphate  esters  were  incubated  with  rabbit  polymorphonudear 
leukocytes in the presence of an inhibitory concentration of phosphonate ester. 
At the end of the incubation period the cells were washed and tested for their 
ability to respond to the chemotactic factor. As will be shown, acetate esters of a 
particular  type, and only acetate esters,  were found capable of protecting the 
rabbit leukocyte against this cell-dependent inhibition by phosphonates. More- 
over,  the conditions under which the protection could be demonstrated  were 
those to be expected if the protecting acetate  esters were competing with  the 
phosphonate for the active site of the enzyme. 
Materials and Methods 
The method for collecting the rabbit polymorphonuclear leukocytes and carrying out the 
tests of chemotaxis were the same as described in the preceding paper (1). The p-nitrophenyl 
ethyl 5-chloropentyl phosphonate, the p-uitrophenyl ethyl hexyl phosphonate, p-nitrophenyl 
ethyl phenylpropyl phosphonate, and p-nitrophenyl ethyl phenylbutyl phosphonate were the 
same as used in the preceding study) Ethyl formate, ethyl acetate,  ethyl propionate,  ethyl 
butyrate, butyl acetate,  glyceryl triacetate  (triacetin),  acetylcholine bromide, and  p-nltro- 
phenyl acetate,  were Eastman White Label chemicals, or of equivalent quality. The acetoxy 
acetic  acid was obtained  from Aldrich  Chemical Co., Inc., Milwaukee, Wis. The tosyl-L- 
arginine methylester  (TAMe), acetyl-L-tyrosine ethyl ester, and glycine ethyl ester were from 
Mann Research  Laboratories,  N.Y. The adenosine 5rtriphosphate  (ATP),  and 1,6-fructose 
diphosphate were from Sigma Chemical Co., St. Louis, Mo. The 6-glucose phosphate  was 
2 In what follows, the p-uitrophenyl ethyl phosphonates will be named only according to 
the nature of the R group, the presence of the p-nltrophenoxy and ethoxy groups being im- 
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from the  Schwarz Laboratories Inc., N.Y.  These phosphates and the  lithium salt of acetyl 
phosphate were generously provided by Dr. L.  Corwin,  Division  of  Biochemistry,  Walter 
Reed Army Institute of Research. 
Medium 199 was used to dissolve the carboxylic acid esters, and phosphonate esters and 
to suspend the polymorphonuclear leukocytes (1). 
The tests of the protective action of the various esters against cell-dependent inhibition by 
the phosphonate were carried out as follows.  In one tube 1 ml of 6 X  10  e polymorphonuclear 
leukocytes was added to 1 ml of the appropriate concentration of the ester whose protective 
ability against inhibition by phosphonates was to be tested, and then 1 ml of an inhibitory 
concentration of phosphonate ester was added. In a second tube, was placed 1 ml of cells,  1 ml 
of the same concentration of ester, and 1 ml of medium 199. The third tube contained 1 ml 
of cells,  1 ml of phosphonate ester, and 1 ml of medium 199. All tubes were allowed to stand 
with intermittent shaking for 1 hr at room temperature and then centrifuged in the cold. The 
leukocytes were washed one time with medium 199, resuspended in 3 ml of medium 199 with 
0.5% ovalbuml- (1), and then tested for their ability to respond to the chemotactic factor as 
described (1). 
In testing the ability of the phosphate, amino acid, and simple carboxylate esters to inhibit 
chemotaxis, 1 mi of 6 X  106 leukocytes was mixed with I ml of ester at three times the desired 
final concentration, and 1 ml of 0.5% ovalbumin, all in medium 199. This cell suspension was 
placed in the upper compartment of the chamber and the ability of the cells to respond to the 
chemotactic factor present in the lower compartment of the chamber was tested in the usual 
way (1). 
The esterase activity of the intact leukocytes against the various carboxylic and phosphate 
esters was measured manometrically in the Warburg apparatus. 15-ml flasks were employed; 
the number of cells was 7.5 X  l0  T  unless otherwise indicated, and the final ester concentration 
0.02 ~¢, bicarbonate concentration 0.024 ~¢, all at a pH of 7.4 in a total volume of 3 ml of 0.15 M 
NaC1. The suspension was equilibrated with 5% COs and 95% N2 at 37°C. 
The inhibition of the aliesterase activity of the polymorphonuclear leukocytes by phos- 
phonate esters was determined by incubating for 1 hr at room temperature 1 volume of 1.3 X 
106--2.3 X  108/ml leukocytes in 0.15 ~¢ saline, with 1 volume of three times the desired con- 
centration of phosphonate in medium 199, and 1 volume of medium 199. At the end of the 
hour, 0.4 ml of the mixture was pipetted into a  Warburg flask, containing 2.6 ml of the ear- 
boxylic add ester, and bicarbonate in 0.15 M saline. The final concentration of carboxylic add 
ester and bicarbonate was the same as described above. 
RESULTS 
The Chemical Nature of the Esters which Protect against Phosphonate Inhibition 
of Chemotaxis.--Table  I  shows the results of studies  testing the ability of a 
variety of simple carboxylic  acid  esters,  amino  acid esters,  and phosphonate 
esters  to prevent the cell-dependent  inhibition of the chemotactic ability of 
rabbit  polymorphonuclear leukocytes by 5  X  10"-4 ~  5-chloropentyl  phos- 
phonate. As noted in the section on Materials and Methods, every ester tested 
for its protective ability was also tested for its effect on the chemotactic behavior 
of the leukocytes after incubation for 1 hr with the leukocytes in the absence of 
the phosphonate. None of the esters reported in Table I had any irreversible 
effect on  the chemotactic responsiveness  of the leukocytes.  All  experiments 
whose results are given in Table I were done at least twice. Glyceryl triacetate 
(triacetin) was used as the standard protecting agent in every experiment. 
The high degree of specificity of the structure of those compounds  able to 1024  CHARACTERIZATION  OF  THE  ACTIVATED  ESTERASE 
TABLE  I 
Specificity of the Prevention by Various Esters of the Cell-Dependent Inhibition  of Chemotaxis 
Induced by 5-Cldoropentyl Phosphonate 
Experi-  Ester  Inhibition  merit 
A 
B 
C 
D 
E 
Glyceryl triacetate (8.3  X  10  --3 it) 
Glyceryl triacetate (3.3  X  10  --8 it) 
Ethyl formate (8.3  X  10-  3 it) 
Ethyl acetate (8.3  X  10-  3 it) 
Ethyl propionate (8.3  X  10-  3 it) 
Ethyl butyrate (8.3  X  10-  3 it) 
Adenosine 5'tfiphosphate (3.3  X  10  -3 it) 
Fructose 1,6-diphosphate (3.3  X  10-  3 it) 
Glucose 6 phosphate (3.3  X  10-  3 M) 
Glyceryl triacetate (8.3  X  10  -3 M) 
Butyl acetate (8.3  X  10  _3 it) 
Glyceryl triacetate (8.3  X  10-  3 it) 
Tosyl-t.-arginine methylester (1 X  10-  2 it) 
Acetyl-L-tyrosine ethylester (5 X  10  -3 it) 
Acetylcholine (1 X  10  -~ it) 
Glyceryl triacetate (8.3  X  10  -3 it) 
Glycine ethylester (8.3  X  10-  8 it) 
Acetoxyacetic acid (8.3  X  10  -~ it) 
Sodium ~-glycerophosphate (8.3  X  10  -3 it) 
Glyceryl triacetate (8.3  X  10  -3 it) 
Glyceryl triacetate (3.3  X  10  -s it) 
Acetylphosphate (8.3  X  10  -3 ~)* 
Acetylphosphate (3.3  X  10  --3 it) 
Acetoxyacetic acid (8.3  X  10-  3 •) 
Acetoxyacetic acid (3.3  X  10- 3it) 
Sodium acetate (8.3  X  10  -3 it) 
5-Chloropentyl  No.  of cells 
phosphonate  responding 
5 X  10-~ 
--  282 
+  176 
+  285 
+  246 
+  189 
+  302 
+  169 
+  148 
+  150 
+  150 
+  147 
--  210 
+  150 
+  233 
+  225 
-  177 
+  8O 
+  175 
+  68 
+  91 
+  83 
--  185 
+  96 
+  180 
+  98 
+  147 
+  66 
--  211 
+  100 
+  226 
+  159 
+  196 
+  119 
+  194 
+  160 
+  102 
% 
38 
0 
13 
33 
0 
4O 
53 
47 
47 
48 
29 
0 
0 
55 
1 
61 
49 
53 
48 
3 
47 
21 
65 
52 
0 
24 
5 
42 
7 
23 
51 
* Somewhat less than 8.3 X  10  -3 it because of slight insolubility of this concentration of 
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protect is evident from Table I. The only esters able to prevent 5-chloropentyl 
phosphonate from inhibiting the chemotactic responsiveness of rabbit leuko- 
cytes were the acetates, glyceryl triacetate, ethyl acetate, butyl acetate, acetoxy 
acetic acid (CHsCOOCH~COOH),  and acetyl phosphate. Acetylcholine, how- 
ever, was not able to protect, nor was sodium acetate. Other simple esters such 
as ethyl formate, ethyl propionate, and ethyl butyrate were not protective. All 
three amino acid esters tested including ethyl glycine (ethyl a-amino acetate) 
were inactive, as were the phosphate esters exept acetyl phosphate. 
Ability of Glyceryl Triacetate  to Protect against  Inhibition  by  Various Phos- 
phonate  Esters.--If  the  protection afforded the  chemotactic capacity of  the 
TABLE II 
The Ability of Glyceryl Triaoetate  to Prote,  t Against Cell-Dependent  Inhibition by Four 
Pkospkonate Esters 
Experi-  Phosphonate  Glyceryl  Ceils responding  ment  triseetate  to chemotactic  Inhibition  factor 
% 
A 
m 
Phenylpropyl (3.3 X 10  -4 5) 
Phenylpropyl (3.3 X 10  -4 5) 
Hexyl (2.5 X 10  -4 '-0 
Hexyl (2.5 X I0  -~ 5) 
Phenylbutyl (2 X 10  -~ u) 
Phenylbutyl (2 X 10  -~ 5) 
5-chloropentyl (5 X 10  -~ M) 
5-chloropentyl (5 X 10  --4 5) 
M 
8.33 )< 10  --8 
8.33 X 10  -8 
8.33  X  10  -3 
8.33 X 10  -8 
280 
139 
238 
167 
216 
130 
8 
108 
55 
122 
50 
15 
41 
23 
94 
17 
48 
6 
polymorphonuclear leukocyte by  the  various  acetate  esters  is  due  to  their 
ability to compete with the phosphonate for the active site d  the enzyme, then 
the protection should be demonstrable with  phosphonates other than the $- 
chloropentyl phosphonate. Table II shows that this is the case.  Glyceryl tri- 
acetate (triacetin) is able to protect the chemotactic capacity of rabbit leuko- 
cytes not only against cell-dependent inhibition by 5-chloropentyl phosphonate, 
but also against inhibition by the hexyl, phenylpropyl, and phenylbutyl phos- 
phonates (Table II). The hexyl and phenylbutyl phosphonates are the two most 
potent inhibitiors of the activated esterase so far known (see reference I). 
The Degree of Protection  as a Function of the Concentration  of Phosphonate 
Inkibitor and of Carboxylic Acid Ester.--If the protection afforded the leukocyte 
by the acetate esters is due to competition with the phosphonate for the active 
site of the  enzyme,  then the  degree of protection should depend on the rel- 
ative  concentrations  of  inhibitor  and  protector.  This  was  tested  by  deter- 1026  CIIARACTERIZATION O~  THE  ACTIVATED ESTERA.SE 
mining the protection afforded by various concentrations of glyceryl triacetate 
at different levels of hexyl phosphonate. The results  are shown in Table III. 
There it is seen  that  8.3  X  10  --3 M glyceryl triacetate  was unable  to protect 
against inhibition by 5.0 X  100' M hexyl phosphonate. The same concentration 
of  glyceryl  triacetate  completely  protected  the  chemotactic  activity  of  the 
leukocyte against the 29 %  inhibition given by 2.0 X  10  °4 ~  phosphonate. Re- 
ducing the concentration of glyceryl triacetate to 4.7  X  10  -* ~  in the presence 
of the same low concentration of phosphonate resulted in only 41% protection3 
TABLE III 
The Effect of Variation of the Concentrations of Hexyl Phosphonate and Glyceryl Triacaate on 
the Degree of Protection 
Concentration of  Concentration of  No. of cells responding  Inhibition 
hexyl phosphonate  glyceryl triacetate  to  chemotactic factor 
10  -.4 ,M" 
0 
10-* 
0 
0 
8.3 
4.1 
275 
% 
100 
100 
100 
100 
3.5 
3,5 
3.5 
2.5 
2.5 
2.5 
2.0 
2.0 
2.0 
0 
8.3 
4.1 
0 
8.3 
4.1 
0 
8.3 
4.1 
57 
76 
53 
162 
211 
194 
196 
275 
229 
79 
72 
81 
41 
23 
30 
29 
0 
17 
Results intermediate  to these were obtained at intermediate  concentrations of 
phosphonate. 
The Correspondence  between the A bihty  of Carboxylic  Add Esters  to Protect 
against Cell-Dependent  Inhibition by Phosphonates and Their Ability to Serve as 
Direct Inhibitiors of Chemotaxis.--If a  carboxylic acid ester can compete with 
the phosphonate for the  active  site  of the  enzyme,  the  carboxylic acid  ester 
should also be able to compete for the same enzyme site with the natural sub- 
strate  in  the  leukocyte.  This  implies  that  those  carboxylic acid  esters  which 
3 Per cent protection is defined as the difference between the per cent inhibition due to the 
phosphonate alone and the per cent inhibition due to the phosphonate in the presence of the 
protective substance divided by the inhibition due to pbosphonate alone, all multiplied by 100. ELMER L. BECKER AND  PETER A.  WARD  1027 
protect against cell-dependent inhibition of chemotaxis by phosphonates should 
themselves prevent chemotaxis. 
The ability of various esters to prevent chemotaxis was tested as described in 
the section on Materials and Methods. Table IV shows the results obtained. Of 
the esters tested,  glyceryl triacetate,  ethyl acetate,  and  butyl acetate when 
mixed with the cell suspension in the upper compartment of the chamber inhib- 
ited  chemotaxis  whereas,  acetylcholine, ethyl  formate,  and  ethyl  butyrate 
were inactive. The slight inhibition obtained with ethyl propionate was con- 
firmed in a subsequent experiment. It is of interest, although not germane to the 
TABLE IV 
Prevention  of Chemotaxis by Ester Substrates 
Experiment  Ester  Concentra-  No. of cells  Inhibition 
tion  responding 
10-s u  % 
A 
B 
D 
Glyceryl triacetate 
Acetyl-L-tyrosine  ethylester 
Tosyl-L-arginine  methylester 
8.3 
5.0 
t0 
138 
63 
20 
135 
Acetyleholine 
Glyceryl triacetate 
Butyl acetate 
Ethyl acetate 
Ethyl formate 
Ethyl propionate 
Ethyl butyrate 
Adenosine 5'triphosphate (ATP) 
Glucose 6-phosphate 
Fructose 1,6-diphosphate 
10  128 
188 
8.3  101 
8.3  100 
8.3  130 
8.3  198 
8.3  164 
8.3  199 
3.0  90 
10  195 
10  190 
54 
86 
2 
7 
46 
47 
31 
0 
14 
0 
52 
0 
0 
present paper,  that acetyl-L-tyrosine ethyl ester and ATP were also effective 
inhibitors, even though amino acid esters such as tosyl-L-arginine methyl ester, 
and phosphate esters such as glucose 6-phosphate and fructose 1, 6-diphosphate, 
were not. The prevention of chemotaxis by acetyl-L-tyrosine ethyl ester and 
ATP is presumably due to mechanisms other than the inhibition of the ac- 
tivated esterase. 
Inability to Relate the Activated Esterase of Chemotaxis to Known Aliesterase(s). 
--Rabbit  leukocytes contain  an  aliesterase  or  esterases  capable  of  splitting 
ethyl formate, ethyl acetate, ethyl propionate, and ethyl butyrate (3, 4). It was, 
therefore, of interest to see if the activated esterase of chemotaxis could be 
related to this known aliesterase(s). 
Rabbit leukocytes were incubated for 1 hr at room temperature with con- 1028  CHARACTERIZATION  OF  THE  ACTIVATED  ESTERASE 
centrations of 5-chloropentyl phosphonate varying from 6.0 X  10  -4 M to 3.8 X 
10-  9 M. The esterase activity remaining on the leukocyte was then determined 
using 0.02  ~t glyceryl triacetate, butyl acetate, or ethyl butyrate as the sub- 
strate. Table V shows that the concentration of phosphonate which gave 50 % 
inhibition of esterase activity with each substrate was somewhat above 6.0 X 
10-9-3.8  X  10-  9 M. This level of the 5-chloropentyl phosphonate is about 10,000 
times less than the concentration, which under essentially the same conditions, 
gives 50%  cell-dependent inhibition of chemotaxis (1).  These results indicate 
that the activated esterase of chemotaxis is not the same as  the aliesterase 
TABLE  V 
Effect  of 5-Chloropentyl Phosphonate  on Aliesterase Activity of Rabbit Polymorphonuclear 
Leukocytes 
Substrate*  No. of leukocytes  Phosphonate  Activity  Inhibition  per Warburg flask  concentration 
% 
Glyceryl triacetate 
Butyl acetate 
Ethyl butyrate 
6  X  l0  T 
6  X  10  7 
4  X  107 
M 
0 
6.7  X  10-  8 
1.5  X  10-  8 
3.8 X  10-  9 
0 
9.4 X  10  -8 
2.4 X  10-  8 
6.0 X  10-  9 
0 
9.4 X  10  -s 
2.4 X  10  -8 
6.0 X  10  -9 
Izl COff  kr 
210 
20 
47 
180 
102 
8 
36 
90 
321 
0 
165 
293 
90 
77 
14 
92 
65 
12 
100 
49 
9 
* In each case, the concentratioa of substrate was 0.02 •,  NaHCO3 0.02 ~, NaCI'0.15 ~t, 
pH 7.4 and total volume 3.0 ml. 
responsible for splitting glyceryl triacetate, butyl acetate, and ethyl butyrate. 
Moreover, it confirms the hypothesis of Wong and Rossiter (4)  that the same 
enzyme is responsible for splitting all of the latter three substrates. 
DISCUSSION 
The protection afforded by the carboxylic acid esters against inhibition of the 
activated esterase of chemotaxis by phosphonates is highly specific (Table I); 
it is not restricted to a single phosphonate (Table II); and the degree of protec- 
tion depends upon the relative concentrations of protective ester and inhibitor 
(Table III). These findings are expected if the carboxylic acid ester competes 
with the phosphonate for the enzymatic site of the activated esterase. The find- 
ing that the protective esters are able to prevent chemotaxis (Table IV) is also in ELMER  L.  BECKER  AND  PETER  A.  WARD  1029 
accord with the hypothesis that these esters combine with the enzymatic site of 
the activated esterase. 
The specificity in the structure of the protective esters is striking. The ester 
must be an acetate; ethyl acetate protects, but ethyl formate with one less 
carbon, or ethyl propionate with one more does not. Butyl acetate protects; its 
isomer, ethyl butyrate, is completely inactive. Acetyl phosphate protects, but 
the other three phosphates tested which lacked the acetyl group did not. Yet, 
not all acetates protect. Acetylcholine in which the acetate is esterified to a 
positively charged alcohol is completely inactive as a protecting agent. How- 
ever, acetoxyacetic acid in which the acetic acid is esterfied to the negatively 
charged 2-hydroxyacetic acid, and acetyl phosphate, in which the acetic acid is 
bound to the negatively charged phosphate are protective. Glycine ethyl ester, 
in which the acetic acid contains an amino group on the a-carbon is not protec- 
tive. Moreover, an ester linkage seems necessary; sodium acetate is not protec- 
tive. 
The protection tests only indicate, in a  qualitative fashion, that the cell- 
bound-activated esterase is able to bind the protecting ester to the active site of 
the enzyme. They do not specify that the enzyme is capable of splitting the 
esters. Thus, it is impossible to state that the activated esterase is able to hy- 
drolyze any of the esters which were found to be protective. Nevertheless, on 
the basis of the work described here, one can say that the activated esterase of 
chemotaxis is an enzyme capable of being competitively inhibited by, or of 
hydrolyzing, neutral acetate esters, and acetates bound to negatively charged 
groups, or of doing both. Acetylesterases (acetylases) are the presently known 
enzymes which best fit these specificity characteristics. The best known acetyl- 
esterase  is  citrus  fruit  acetylesterase (5-7),  but similar enzymes have been 
reported in mammalian tissue as well (8). They have not been reported in mam- 
malian leukocytes. On the basis of this work a  search for such an enzyme in 
rabbit polymorphonuclear leukocytes is indicated. 
The 10,000-fold  difference in sensitivity to phosphonate inhibtion between 
the known aliesterase of rabbit leukocytes and the activated esterase of chem- 
otaxis (Table V) indicates that the two esterases are different. Experiments not 
reported here suggest that the activated esterase is not part of the endogenous 
or exogenous glycolytic cycle of the leukocyte. In the presence and absence of 
added glucose, acid production as measured in the Warburg apparatus was un- 
affected by prior treatment of the leukocyte with concentrations of 5-chloro- 
pentyl, hexyl, or phenylbutyl phosphonate capable  of giving 70-100%  cell- 
dependent inhibition. 
To the extent that an enzyme is defined in terms of the substrates upon which 
it acts, neither this work, nor that reported in the preceding paper, has identified 
the  activated esterase.  Nevertheless,  the phosphonate inhibition profiles re- 
ported in the preceding study, and the specificity of the binding of acetates to 1030  CHARACTERIZATION O1~  THE  ACTIVATED ESTERASE 
the active site of the enzyme described here should make such an identification 
possible. This awaits further work. 
SUMMARY 
It was shown in the preceding paper that incubation of the rabbit poly- 
morphonuclearlcukocytcs with phosphonate esters  leads  to  an  irreversible  inhibi- 
tion of the ability  of the leukocyte to respond to the chemotactic factor.  This 
"cell-dependent inhibition" was attributed to the inactivation by the phos- 
phonates of an esterasc  existing  in or on the leukocyte in an already activated 
state. As shown in this  paper, incubating the leukocyte with phosphonate in 
the presence of certain esters prevents  this cell-dependent inhibition. The 
protection is specific;  the ester  must bc an acetate.  Ethyl formate, ethyl  pro- 
pionate, ethyl  butyrate, glucose 6-phosphate, fructose 1,6-diphosphate, ATP, 
tosyl arginine  methyl ester,  or acetyl tyrosine ethyl  ester  do not protect.  The 
protection is  independent of the phosphonatc used to inhibit,  and the degree of 
protection depends on the relative  concentrations of acetate and phosphonate. 
Those acetates  which protect arc also  the esters  which inhibit  chemotaxis when 
added to the leukocyte in the upper part of the chemotaxis chamber. It is  con- 
cludcd that the activated csterase  is  an enzyme capable of specifically  splitting, 
or binding acetates, or doing both. Presumably the estcrase  is some type of 
acetylestcrase or acctylase.  The known alicsterase  present in the leukocyte is 
not the activated csterasc.  Inhibition  of the activated esterase  by phosphonates 
has no effect  on endogenous or exogenous glycolysis. 
BIBLIOGRAPHY 
I. Ward, P. A., and E. L. Becker.  1967.  Mechanisms of the inhibition  of chemotaxis 
by phosphonate esters. J. Exptl. Med. 19.5:1001. 
2.  Becker, E. L.  1961. Early steps in immune hemolysis.  In Immuuochemical Ap- 
proaches to Problems in Microbiology. M. Heidelberger and O. J. Plescia, editors. 
The Rutgers University Press, New Brunswick.  245. 
3.  Rossiter,  J. R., and E. Wong.  1949. Esterase of rabbit polymorphonudear leuko- 
cytes. J. Biol. Chem. 180:933. 
4.  Wong,  E.,  and  J.  R.  Rossiter.  1951. Aliesterase  of  rabbit  polymorphonudear 
leukocytes.  Nature. 168:80. 
5.  Jansen, E. F., R. Jang, and L. McDonnell.  1947. Citrus acetylesterase.  Arch. Bio- 
chem. Biophys. 15:415. 
6.  Jansen, E. F., M. D. Fellows-Nutting, and A. K. Balls.  1948. The reversible in- 
hibition of acetylesterase by diisopropyl fluorophosphate and  tetraethyl pyro- 
phosphate. J. Biol. Chem. 175:975. 
7.  Ooms, A. J. J., J. C. A. E. Breebaart-Hansen, and B. I. Ceulen.  1966. The reaction 
of organophosphorus compounds with hydrolytic enzymes. II. The inhibition  of 
citrus acetylesterase. Biochem.  Pharmacol. 16:17. 
8.  Ecobichon,  D. J., and W. Kalow. 1964. Properties and classification of the soluble 
esterases of human kidney. Canad.  J. Biockem. Physiol. 49.:277. 